DSIP’s unidentified precursor
Blood, milk, a known sequence. Somewhere upstream, the account of how the body makes DSIP still has a missing entry.
The precursor question
In their 2006 review, Kovalzon and Strekalova described a peptide with no identified gene, precursor protein or specific receptor. DSIP already had its sequence and a long list of proposed effects. Its biological source remained unfinished business.
The unidentified precursor became my main question. Another sleep claim could wait. A precursor is the larger protein from which a peptide is made. For DSIP, that upstream protein has never been conclusively identified. The chain can be written down; the account of its production remains open.
To me, finding the precursor would be a substantial advance even before another experiment reported better sleep. It would give the rest of this literature a firmer place to begin.
Original DSIP
The original DSIP sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu: nine amino acids in a particular order. The 1977 characterization established that sequence after the peptide was isolated from blood near the brains of rabbits in electrically induced sleep. Infusion into the rabbit brain enhanced delta and spindle activity on the EEG, the recording of electrical activity in the brain.
That experiment supplied an identity and a measurable effect. The later search for a gene and precursor asked a different question: how does the body produce this particular chain? I expected an amino-acid sequence to provide a route back to its origin. The review broke that assumption.
The identity and origin of DSIP deserve their own page, including the formal name emideltide and the meaning of phospho DSIP.
DSIP in bodily fluids
DSIP has been reported in plasma, cerebrospinal fluid and milk, often attached to a carrier protein. The older review literature describes its distribution and uncertain physiological role. Cerebrospinal fluid is the liquid surrounding the brain and spinal cord; finding a peptide there still leaves the question of where it began.
A carrier protein and a precursor serve different purposes. Attachment in blood tells us about the form in which DSIP travels. It does not identify the protein from which the chain was produced. Conflating the two would make this source trail look much more complete than it is.
Hormone and opioid findings
The missing origin has never stopped experimenters from asking what DSIP can do. One human study measured a fall in ACTH-like immunoreactivity while cortisol remained unaffected. Another experiment used rat brainstem slices to investigate release of an opioid peptide. These are quite different pieces of the biological puzzle, with quite different subjects.
I prefer these specific results to the sweeping description of DSIP as a sleep-and-recovery substance. They leave something definite to investigate. The research record follows the human sleep tests, the hormone measurements and the rat-tissue experiment separately; reported effects deals with the much looser personal accounts.
DSIP has no FDA-approved medical use. Its unresolved biology sits alongside substantial gaps in human safety data. Curiosity about its source offers no assurance about using it.